| pubmed-article:10524651 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10524651 | lifeskim:mentions | umls-concept:C0027651 | lld:lifeskim |
| pubmed-article:10524651 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:10524651 | lifeskim:mentions | umls-concept:C0206646 | lld:lifeskim |
| pubmed-article:10524651 | lifeskim:mentions | umls-concept:C0076836 | lld:lifeskim |
| pubmed-article:10524651 | lifeskim:mentions | umls-concept:C0085970 | lld:lifeskim |
| pubmed-article:10524651 | lifeskim:mentions | umls-concept:C0450442 | lld:lifeskim |
| pubmed-article:10524651 | lifeskim:mentions | umls-concept:C0023866 | lld:lifeskim |
| pubmed-article:10524651 | lifeskim:mentions | umls-concept:C0814812 | lld:lifeskim |
| pubmed-article:10524651 | pubmed:issue | 10 | lld:pubmed |
| pubmed-article:10524651 | pubmed:dateCreated | 1999-12-17 | lld:pubmed |
| pubmed-article:10524651 | pubmed:abstractText | Desmoid tumours are histologically benign but due to their infiltration and compression of surrounding structures potentially life-threatening fibromatous lesions of unknown aetiology. The annual incidence rate is 2-4 per million people. The mesenteric variant constitutes about 10% of all desmoid tumours, although in familial adenomatous polyposis (FAP) patients this may be up to 70%. Due to the small number of patients with mesenteric desmoids the therapy is mainly empirical. This report describes the rationale as well as the value of the short- and long-term treatment (up to 6 years) with the anti-oestrogenic agent toremifene in combination with sulindac in two patients suffering from such a mesenteric desmoid tumour. These patients did not respond to sulindac alone and previous treatment with tamoxifen together with this non-steroidal anti-inflammatory drug had also failed. An overview of the literature on the management of these dismal tumours is presented. | lld:pubmed |
| pubmed-article:10524651 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10524651 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10524651 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10524651 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10524651 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10524651 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10524651 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10524651 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10524651 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:10524651 | pubmed:issn | 0954-691X | lld:pubmed |
| pubmed-article:10524651 | pubmed:author | pubmed-author:LamersC BCB | lld:pubmed |
| pubmed-article:10524651 | pubmed:author | pubmed-author:KeizerH JHJ | lld:pubmed |
| pubmed-article:10524651 | pubmed:author | pubmed-author:van... | lld:pubmed |
| pubmed-article:10524651 | pubmed:author | pubmed-author:VerspagetH... | lld:pubmed |
| pubmed-article:10524651 | pubmed:author | pubmed-author:VakilR JRJ | lld:pubmed |
| pubmed-article:10524651 | pubmed:author | pubmed-author:GriffioenGG | lld:pubmed |
| pubmed-article:10524651 | pubmed:author | pubmed-author:de RoosAA | lld:pubmed |
| pubmed-article:10524651 | pubmed:author | pubmed-author:BemelmanW AWA | lld:pubmed |
| pubmed-article:10524651 | pubmed:author | pubmed-author:OEIE DED | lld:pubmed |
| pubmed-article:10524651 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10524651 | pubmed:volume | 11 | lld:pubmed |
| pubmed-article:10524651 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10524651 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10524651 | pubmed:pagination | 1179-83 | lld:pubmed |
| pubmed-article:10524651 | pubmed:dateRevised | 2009-10-16 | lld:pubmed |
| pubmed-article:10524651 | pubmed:meshHeading | pubmed-meshheading:10524651... | lld:pubmed |
| pubmed-article:10524651 | pubmed:meshHeading | pubmed-meshheading:10524651... | lld:pubmed |
| pubmed-article:10524651 | pubmed:meshHeading | pubmed-meshheading:10524651... | lld:pubmed |
| pubmed-article:10524651 | pubmed:meshHeading | pubmed-meshheading:10524651... | lld:pubmed |
| pubmed-article:10524651 | pubmed:meshHeading | pubmed-meshheading:10524651... | lld:pubmed |
| pubmed-article:10524651 | pubmed:meshHeading | pubmed-meshheading:10524651... | lld:pubmed |
| pubmed-article:10524651 | pubmed:meshHeading | pubmed-meshheading:10524651... | lld:pubmed |
| pubmed-article:10524651 | pubmed:meshHeading | pubmed-meshheading:10524651... | lld:pubmed |
| pubmed-article:10524651 | pubmed:meshHeading | pubmed-meshheading:10524651... | lld:pubmed |
| pubmed-article:10524651 | pubmed:meshHeading | pubmed-meshheading:10524651... | lld:pubmed |
| pubmed-article:10524651 | pubmed:meshHeading | pubmed-meshheading:10524651... | lld:pubmed |
| pubmed-article:10524651 | pubmed:meshHeading | pubmed-meshheading:10524651... | lld:pubmed |
| pubmed-article:10524651 | pubmed:meshHeading | pubmed-meshheading:10524651... | lld:pubmed |
| pubmed-article:10524651 | pubmed:year | 1999 | lld:pubmed |
| pubmed-article:10524651 | pubmed:articleTitle | Treatment of mesenteric desmoid tumours with the anti-oestrogenic agent toremifene: case histories and an overview of the literature. | lld:pubmed |
| pubmed-article:10524651 | pubmed:affiliation | Department of Gastroenterology-Hepatology, Leiden University Medical Center, The Netherlands. | lld:pubmed |
| pubmed-article:10524651 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10524651 | pubmed:publicationType | Review | lld:pubmed |
| pubmed-article:10524651 | pubmed:publicationType | Case Reports | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10524651 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10524651 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10524651 | lld:pubmed |
